Open Source Pitfalls at the Biotechnology-High Technology Crossover

4 Pages Posted: 4 Jun 2018

See all articles by Paul Liu

Paul Liu

Thomas Jefferson School of Law

Date Written: May 14, 2018

Abstract

Software is eating the biotechnology world. However, managers in the traditional biotechnology sector may not be familiar with open source and related compliance issues that are bound to come up as they develop high technology solutions to the problems of biotechnology. For example, many programmers will utilize open source software to build their software products. Open source software is typically cost-free software code that comes with strings attached. Programmers like to incorporate open source software into their code because there is no point in reinventing the wheel for simple or common software functionalities. However, use of open source software has specific compliance requirements in order to not be in violation of open source licenses. As software projects become larger and more valuable, proper records and documentation become more important to keep and more difficult to comply with.

Keywords: open source, biotechnology, software, compliance, intellectual property, IP, copyleft, FDA, Broad Institute, Ilumina, GATK, Google, deep vatiant

Suggested Citation

Liu, Paul, Open Source Pitfalls at the Biotechnology-High Technology Crossover (May 14, 2018). Bio-IT World (May 14, 2018), Thomas Jefferson School of Law Research Paper No. 3189002, Available at SSRN: https://ssrn.com/abstract=3189002

Paul Liu (Contact Author)

Thomas Jefferson School of Law ( email )

701 B Street
Suite 110
San Diego, CA 92101
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
28
Abstract Views
416
PlumX Metrics